Tag Archive for: axial spondyloarthritis

y-s-jrHaA9zyGV0-unsplashUnsplash+
Clinical Data

MoonLake’s sonelokimab shows strong Phase II efficacy in axSpA, challenging UCB’s Bimzelx

Most inflammatory arthritis patients on MoonLake Immunotherapeutics’ sonelokimab met the response criteria, furthering the Swiss biotech’s attempt to challenge UCB for a blockbuster market.

Read more